A Curated Platform of Equity & Options Market Intelligence
Select Page

Unusual Call Buyer in Biotech Sees Major Upside

Unusual Call Buyer in Biotech Sees Major Upside

by | Mar 24, 2022 | Flow Alerts

Y-mAbs (YMAB) unusual 1200 November $17.50 calls opening this morning near $3, shares tightly flagging after a strong run since its latest conference call in February. YMAB has a mostly early stage pipeline while its Danyelza launch in focus currently for investors.